Effectiveness of Trastuzumab in First-Line HER2+ Metastatic Breast Cancer After Failure in Adjuvant Setting: A Controlled Cohort Study — Eva Negri (2014) | RDL Network
Effectiveness of Trastuzumab in First-Line HER2+ Metastatic Breast Cancer After Failure in Adjuvant Setting: A Controlled Cohort Study
Article 2014 en
Authors
EN
Eva Negri
AZ
Alberto Zambelli
MF
Matteo Franchi
Abstract
1 min read
Our data provide convincing evidence that the outcome of women receiving first-line T treatment for mBC after T failure in the adjuvant setting is comparable to that of women not receiving T for eBC. These data are of specific interest, given the unavailability of data from randomized clinical trials.
Eva Negri, Alberto Zambelli, Matteo Franchi, Marta Rossi, Martina Bonifazi, Giovanni Corrao, Antonella Zambon, Lorenzo Moja, Carlo Zocchetti, Carlo La Vecchia
Martina Bonifazi, Matteo Franchi, Marta Rossi, Alberto Zambelli, Lorenzo Moja, Antonella Zambon, Giovanni Corrao, Carlo La Vecchia, Carlo Zocchetti, Eva Negri
Vasilios Karavasilis, Dimitrios Pectasides, Christos Papadimitriou, Helen Gogas, George Kouvatseas, Christos Christodoulou, Αngelos Koutras, George Pentheroudakis, Helena Linardou, E. Razis, Gerasimos Aravantinos, Meletios A Dimopoulos, George Fountzilas
Discussion(0)
No comments yet. Be the first to comment.